GW Pharma Scores New FDA Approval For CBD Drug Epidiolex

GW Pharma Scores New FDA Approval For CBD Drug Epidiolex

Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment of seizures associated with tuberous sclerosis comp…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *